Practice Management News

The AMA House of Delegates adopted several new policies to promote public health at its annual meeting.

Urinalysis did not accurately diagnose UTIs in children with spina bifida, according to study results published in Pediatrics.

The AMA adopted policies to protect patients’ access to necessary health care in a variety of ways at its annual meeting.

In late May, the FDA announced approval of Moderna's mResvia, marking the third vaccine approved for respiratory syncytial virus and first time messenger RNA technology has been used for preventing a disease other than COVID-19.

Researchers developed an electronic health questionnaire for primary care practices that improves the collection of information about adolescents’ health behaviors, according to a study published in Pediatrics.

The AMA adopted new policies on broader Medicare and Medicaid health care coverage during its annual House of Delegates meeting.

The AMA announced a new policy that supports requirements for drug and device sponsors to develop diversity action plans so that women and sexual and gender minorities are adequately represented in their clinical trials.

The AMA House of Delegates adopted two new policies aiming to reform prior authorization and the burden it causes patients and physicians.

The FDA has approved the interleukin-6 inhibitor Kevzara for the treatment of polyarticular juvenile idiopathic arthritis, according to a press release from Regeneron Pharmaceuticals and Sanofi.

The AAP launched a podcast called “Healthy Children” to provide expert medical guidance for parents and other caregivers.